Pazopanib for the treatment of soft-tissue sarcoma

Pazopanib is a multikinase inhibitor which potently inhibits the activity of major receptor tyrosine kinases, including vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, platelet-derived growth factor receptor...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Heudel, Pierre, Cassier, Philippe, Derbel, Olfa, Dufresne, Armelle, Meeus, Pierre, Thiesse, Philippe, Ranchère-Vince, Dominique, Blay, Jean Yves, Ray-Coquard, Isabelle
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2012
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508654/
https://ncbi.nlm.nih.gov/pubmed/23204874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S33195
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg